CJ Bioscience, Inc. (KOSDAQ: 311690)

CJ Bioscience Revenue

CJ Bioscience had revenue of 744.19M KRW in the quarter ending September 30, 2024, a decrease of -55.60%. This brings the company's revenue in the last twelve months to 3.97B, down -29.25% year-over-year. In the year 2023, CJ Bioscience had annual revenue of 5.58B with 36.82% growth.

• Revenue (ttm): 3.97B
• Revenue Growth: -29.25%
• P/S Ratio: 23.26
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 92.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.58B	1.50B	36.82%
Dec 31, 2022	4.07B	-288.37M	-6.61%
Dec 31, 2021	4.36B	-948.52M	-17.86%
Dec 31, 2020	5.31B	528.32M	11.05%
Dec 31, 2019	4.78B	859.18M	21.90%